StonvexLoading…
StonvexStonvexStonvexCore line items from USAR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $5.70M | $1.64M | $0.00 | $0.00 |
Operating Income | $-36.67M | $-59.50M | $-8.72M | $-15.59M |
Net Income | $-66.99M | $-297.56M | $51.83M | $-15.73M |
EPS (Diluted) | $-0.34 | $-3.31 | $0.58 | $-0.40 |
Total Assets | $2.13B | $695.00M | $77.08M | $69.07M |
Total Liabilities | $246.27M | $191.81M | $97.33M | $15.13M |
Cash & Equivalents | $1.75B | $359.93M | $23.35M | $16.76M |
Free Cash Flow OCF − CapEx | $-57.10M | $-86.34M | $-12.34M | $-16.10M |
Shares Outstanding | 217.98M | 148.06M | 81.95M | 60.09M |